chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Red swelling around area of injection developed 1.5 days later. Not itchy but warm and sensitive to the touch.
Client received MMR vaccine and 5-10 seconds later blacked out for 5-10 seconds. Clammy skin, nausea, dizziness. Client monitored then after dizziness continued, client sent to hospital via EMS.
checked blood pressure which had spiked to 176/100; Headache; This spontaneous case was reported by a physician and describes the occurrence of HYPERTENSION (checked blood pressure which had spiked to 176/100) and HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     Previously administered products included for Drug use for unknown indication: Pfizer (Dose 1) and Pfizer (Dose 2). Past adverse reactions to the above products included No adverse event with Pfizer and Pfizer.    On 24-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Nov-2021, the patient experienced HYPERTENSION (checked blood pressure which had spiked to 176/100) and HEADACHE (Headache). At the time of the report, HYPERTENSION (checked blood pressure which had spiked to 176/100) was resolving and HEADACHE (Headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-Nov-2021, Blood pressure measurement: spiked to 176/100.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  Within hours patient experienced headache and checked blood pressure which had spiked to 176/100. Blood pressure remained elevated until 27-Nov-2021 and had moderate relief with a few unspecified blood pressure medications.
First there was an area on the right side of my leg that got numb then spread to foot. Face now feels numb.
received one dose of Shingrix vs 2 doses; This case was reported by a other health professional via sales rep and described the occurrence of incomplete course of vaccination in an unspecified number of patients who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included shingrix (1st dose received on an unknown date).   On an unknown date, the patients did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK receipt date: 26-JAN-2023 Reporter Comment: Submitted via sales rep on behalf of HCP. The reporter reported that, the unknown number of patients may have received one dose of Shingrix versus 2 doses. No other adverse event information available. The reporter consented to follow up. Additional Supportive Information: Till the time of reporting, the patients did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination.
This spontaneous case was reported by a pharmacist and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (patient received vaccine from vial that underwent a temperature excursion), PRODUCT TEMPERATURE EXCURSION ISSUE (vial underwent a temperature excursion) and NO ADVERSE EVENT (No adverse event) in a 34-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7147B) for COVID-19 prophylaxis.     No Medical History information was reported.     The pharmacist reported that, temperature excursion occurred several days ago in the freezer. Multiple patients received vaccine from vaccine that underwent a temperature excursion in the freezer, and they just found out about the excursion in an audit. No adverse event reported for the patient.   No treatment medications were reported.
Information has been received from a physician concerning a 9 year old female who on 13-SEP-2007 was vaccinated with a dose of VAQTA. Suspect vaccination administered that day included a dose of VARIVAX and a dose of FLUZONE. On 14-SEP-2007 the patient was diagnosed with encephalitis characterized by headache, dizziness, stumbling, memory changes, and confusion. The patient was also noted to have mild facial palsy. The patient was seen by the physician and was subsequently hospitalized. The patient was not recovered. There was no product quality complaint. The physician also considered encephalitis and mild facial palsy to be disabling. Additional information has been requested. 10/8/07-records received-for DOS 9/15-9/21/07-DC DX: left basal ganglia infarct. Presented with 2 day history of severe headaches. Noted to have right sided facial droop with confusion. Poor handwriting and slurred speech as well as ataxia with right arm weakness.  Headaches began on day she received vaccines. Ocular disks were only partially visualized. Discharged to rehab. Per 60 day follow up: S/p left cannulate/basal ganglia stroke. Patient has Rt facial palsy (mild), Rt side hemiparesis with spasiticty rt foot, aquired attention deficit disorder iwht impulsive disorder and speech dysfunction. Conditions requires frequent speech therapy, OT and PT as well as behavioral psychological therapy.
Immediately after vaccine administration patient had a syncopal episode. Patient was placed in supine position for 15 min until he felt better. He drank gatorade and left office in good condition after 30 mins.
Raised, red bumps on arms, legs and torso; Raised, red bumps on arms, legs and torso; Body aches; This is a spontaneous report from a contactable other healthcare professional. A 48-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: ER8733) via an unspecified route of administration in left arm on 01Apr2021 at 10:15 (at an age of 48-year-old) as single dose for COVID-19 immunisation.  Medical history included whipple surgery from pancreatic tumor, diabetes, depression and COVID-19. Concomitant medications included nebivolol hydrochloride (BYSTOLIC), pioglitazone (MANUFACTURER UNKNOWN), dapagliflozin propanediol monohydrate (FARXIGA), insulin detemir (LEVEMIR) and semaglutide (OZEMPIC), all from unknown dates and for unknown indications. The patient previously received sulfamethoxazole, trimethoprim (BACTRIM) on an unknown date and experienced allergy. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 06:30 seven days after receiving the first dose of vaccine, the patient experienced raised red bumps on arms, legs, torso. On 09Apr2021 the same night, the patient also experienced body aches when bumps appeared. The patient did not receive any treatment for the reported events. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the events raised red bumps on arms, legs, torso and body aches were not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Redness & swelling at injection site w/in 12 hr. At 24 hours swelling, itching & redness increased to area 7 1/2 inches by 3 inches - continued for 1 week.
Within 12 hours severe abdominal pain, diarrhea and shakes that resolving within 3 hours.
flu shot dont help I took the shot about month later i took the flu got real sick; Initial information received on 11-Feb-2022 regarding an unsolicited valid social media non-serious case was received from a consumer/non-healthcare professional.  This case involves a patient of unknown demographics, who reported that flu shot didn't help the patient took the shot about month later took the flu, got real sick, while being vaccinated with influenza vaccine.  The patient's past medical history, medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided.   On an unknown date, the patient received influenza vaccine (produced by unknown manufacturer) (strength, formulation, dosage regimen, lot number, route, administration site not reported) for prophylactic vaccination.  The patient reported that on an unknown date, the flu shot did not help, he/she took the shot about month later, got real sick (illness) following the administration of influenza vaccine.  Action taken with influenza vaccine was not applicable.  It was not reported if the patient received a corrective treatment for the event.  At time of reporting, the outcome was Unknown for the event.
I got intense body aches around 8 pm the day of the vaccine.  A few hours later I suddenly felt incredibly strong chills and had a slight fever.  If my skin touched the air in my room then that part of my body would ache due to the chills.  The next morning I still had a fever and went through cycles of chills and heat waves in my body.  I also had a lack of interest in food.
Headache, Myalgia, Diarrhea, HYPERglycemia, sugars up by 100 points, diarrhea 6 days Narrative:   Other Relevant History:
This case was reported by a consumer via call center representative and described the occurrence of iron decreased in a 16-year-old male patient who received FLUARIX. Previously experienced adverse reactions included tremor, nausea, anxiety, numbness and tingling (after receiving FLUARIX vaccine in Oct 2014, refers case US2016018245). Previously administered products included Flu vaccine (non-GSK vaccine received prior to 2014 without experiencing any adverse events). Concurrent medical conditions included esophageal acid reflux and pineal gland cyst (since birth). Concomitant products included MENINGITIS VACCINE, omeprazole and vitamin D nos. In October 2015, the patient received FLUARIX (intramuscular). In November 2015, 30 days after receiving FLUARIX, the patient experienced nausea, anxiety, numbness of extremities, tingling feet/hands and panic attack. On an unknown date, the patient experienced iron decreased. The patient was treated with iron. In December 2015, the outcome of the nausea, anxiety, numbness of extremities, tingling feet/hands and panic attack were recovered/resolved. On an unknown date, the outcome of the iron decreased was not recovered/not resolved. It was unknown if the reporter considered the iron decreased, nausea, anxiety, numbness of extremities, tingling feet/hands and panic attack were recovered/resolved. On an unknown date, the outcome of the iron decreased was not recovered/not resolved. It was unknown if the reporter considered the iron decreased, nausea, anxiety, numbness of extremities, tingling feet/hands and panic attack to be related to FLUARIX. Additional details were provided as follows: This case was previously reported to a doctor. This case was reported by the patient's grandmother. In 2015, the patient also had  meningitis vaccine along with flu vaccine, but the reporter thought the patient only had flu vaccine in 2014. The reporter did not know which GLAXOSMITHKLINE flu vaccine the patient received. In November 2015, approximately 1 month after receiving the vaccine, the patient experienced nausea, anxiety, numbness and tingling in hands and feet, and panic attack (same symptoms occurred after vaccinated in October 2014 except the tremors). The patient had a total of 2 panic attacks that required a visit to the emergency room (ER) between November 2015 and December 2015. The patient sometimes had more minor symptoms that subsided without medical attention. This year the symptoms were more concentrated on the patient's right side. In 2015, the patient underwent laboratory test such as Magnetic Resonance Imaging (MRI), Electroencephalogram (EEG) and Computerized tomogram (CT), but all that was found was a cyst on the patient's pineal gland that was thought to be benign and something he was born with. Since December 2015, the patient did not experience any event. At the time of reporting, the patient had started having low iron levels.
10/4/21 3:31 pm Client feels the vaccine was working. States he couldn't move his hands and his family got COVID and he didn't. States he will get another shot after Oct. 18, 2021 since he got the second dose on 9/20/21. He requested a messege be sent.  10/18/21 1419 message sent to come in for vaccine. Client called stating he is does not want a third shot.
After about 10 minutes of receiving his first dose of Moderna vaccine, pt experienced nausea, dry heaving, and moderate diaphoresis.  First set of vitals:  HR: 68, BP:  117/77. O2 Sat 98%.  Pt was given apple juice.  He felt better.  Nausea and diaphoresis resolved.  2nd set of vitals: HR: 67.  BP: 114/81.   O2 Sat 98%. Pt then started to complain of mild blurry vision.  3rd set of vitals:  HR: 66.  BP: 115/83.  O2 Sat 97%.  Continued to monitor pt.  Blurry vision resolving. Pt states that he is ok to leave clinic and go home.  Pt accompanied by friend who will drive him home.  Pt is ambulatory.  Able to walk out of clinic independently.  Condition stable.
Patient experienced moderate to severe symptoms of shaking, trouble breathing, jaw tightness, tightness in mouth, numbness and tingling in lips, difficulty talking, upset stomach, tremors and numbness to left side of face
Itchy, bumpy rash at site of injection. The rash/bumps are continuing for more than 3 days.
Shoulder pain and inability to move arm after 2nd shot. Which was in January 2019. Shoulder pain progressed, reported to doctors and they said it was nothing. Got 3rd shot on 7/12/2019 and on 7/15/2019 had shoulder pain that made me call off of work, joint was stiff for at least 3 days. Over the last months pain and inflammation has spread to neck, both shoulders, fingers are swollen and has now spread to feet.
Twenty four hours post vax, pt experienced a febrile seizure. His temperature was 102F. Forty eight hours post vax, pt had a second febrile seizure.
Pfizer-BioNTech COVID-19 Vaccine EUA: two months after vaccination patient admitted to hospital for elective surgery (LSD and HHR) complicated by postoperative hypoxemia and significant nausea/vomiting. Discharged to home medically stable and continues to improve: on clinic follow-up provider documented patient is recovering well and no complications.
Information has been received from a health professional concerning a 7 year old male pt who on 14-JUL-1997 was vaccinated with a dose of varicella virus vaccine live. Subsequently, on approximately 23-APR-2004, the pt developed breakthrough chickenpox with 50 to 500 lesions. Follow up information indicated that "there was no single report of adverse reaction following varicella vaccination". The reporter indicated that 49 other patients developed breakthrough cases of chickenpox (WAES0404USA02615, WAES0405USA00572, WAES0405USA00573, WAES0405USA00574, WAES0405USA00575, WAES0405USA00576, WAES0405USA00577, WAES0405USA00578, WAES0405USA00579, WAES0405USA00580, WAES0405USA00581, WAES0405USA00582, WAES0405USA00583, WAES0405USA00584, WAES0405USA00585, WAES0405USA00586, WAES0405USA00587, WAES0405USA00588, WAES0405USA00589, WAES0405USA00590, WAES0405USA00591, WAES0405USA00592, WAES0405USA00593, WAES0405USA00594, WAES0405USA00595, WAES0405USA00596, WAES0405USA00597, WAES0405USA00598, WAES0405USA00599, WAES0405USA00600, WAES0405USA00601, WAES0405USA00602, WAES0405USA00603, WAES0405USA00604, WAES0405USA00606, WAES0405USA00607, WAES0405USA00608, WAES0405USA00609, WAES0405USA00610, WAES0405USA00611, WAES0405USA00612, WAES0405USA00613, WAES0405USA00614, WAES0405USA00615, WAES0405USA00616, WAES0405USA00617, WAES0405USA00618, and WAES0405USA00619). No additional information is expected.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. On or about 03-NOV-2015, the patient was inoculated with ZOSTAVAX, at a public health department, (by an unspecified health care professional) as recommended for routine adult health maintenance for the prevention of shingles (dose, route, and lot # not provided). The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain condition of herpes zoster. On or about 28-JUN-2016, the patient was treated by a physician at a clinic for a blistering vesicular outbreak, which was diagnosed as shingles. The patient has been prescribed famiciclovir for management of her painful symptoms. As a direct and proximate result of ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was related.  Additional information has been requested.
This spontaneous report as received from a doctor of pharmacy refers to a patient who was vaccinated with an improperly storage dose of ZOSTAVAX (lot # 672609/1733AA, expiration date 04-FEB-2013, dose not reported) on 13-AUG-2012. No other co-suspects were reported. No concomitant medications were reported. The doctor of pharmacy reported that one of the facilities that he was in charge of was recording the temperature of the storage unit of ZOSTAVAX as -5F. He reports that they recently discovered that the actual temperature of the storage unit was -5C. He did not know if the patient had experienced any adverse effects. This is one of several reports received from the same source. This report is cross referenced with the following MARR #: 1209USA002918, 1210USA006055, 1210USA006056, 1210USA006057, 1210USA006058, 1210USA006059, 1210USA006060, 1210USA006061, 1210USA006062, 1210USA006063, 1210USA006064, 1210USA006065, 1210USA006066, 1210USA006067, 1210USA006069, 1210USA006070, 1210USA006071, 1210USA006072, 1210USA006073, 1210USA006074. Additional information is not expected.
5/4/06 10:00, Rt deltoid red, edematous, warm and tender to touch. Rt deltoid is the site of DTAP No 5. Mom states he had a slight fever last night. Describes him as being "cranky" and clingy. Otherwise, he was smiling, personable and active. Instructed to put ice on it, administer Tylenol or ibuprofen PRN, and continue to monitor. If no improvement/resolution in several days-call again.
Tennis ball size swelling and redness, hot to touch Rt deltoid, pt c/o itching, no c/o soreness or pain, free ROM. DTAP given at this site 48 hrs ago. pt tx. with Benadryl per MGM on 8/11/10 PM. Telephone call 8/12/10 AM says redness and swelling almost gone.
Fainted with seizure in class. Hit head on desk. Paramedic was called and was taken to ER.
Information has been received from a pharmacist concerning a male (age not reported) who was vaccinated with a dose of zoster vaccine live (Oka/Merck). Subsequently the patient experienced fever of 103.4 F, body aches, stiff neck and nausea approximately 2 - 3 hours after vaccination The patient sought unspecified medical attention. The patient's status was not reported. There was no product quality complaint involved. Additional information has been requested.
For 2 periods after I get a covid shot there are one to 2 days of my period where I am bleeding very badly and I get a lot and they are huge blood clots. After my second dose of the covid vaccine in the middle of my period I think there was a day where in 3 hours time I went through 20 tampons and those tampons were the biggest  tampon you can buy Tampax ultra and each time I took the tampons out in those 3 hours there were 2 golf ball size clots. And then for a couple of weeks or month after I get the vaccine my migrains are extremely horrible and I will have 3 to 4 of them in a week and they will last for a day or so. And it doesn't mated what medicine I'm on it will not prevent them. And then I bruise extremely easy during that time too. Now I got the 3rd shot 2 weeks ago and my period was bad but not as bad as I just described I had huge blood clots not as many and my I had a migraine that lasted for 5 days and I'm bruising extremely easy. Today I barely bumped my hand on something I'm not even sure and I between my thumb and forefinger I got this thing a bump or something but i couldn't hold anything in my hand, everything I would move my hand it would start swelling and then if I was still it would go back down until I moved it again. It felt like I was having a contraction there cuz it would contract with pain and then release and do it all over again . Now 10 hours later I still have the bump or whatever it is there's not as much pain and it isn't swelling I'm allowed movement
Fever 102 degrees, violent chills, headache, overall weakness, extreme pain in arthritic hip and leg. Began around 9pm and lasted through most of the night. Fever, chills subsided by next morning, had minor headache which was resolved with ibuprofen. No lingering symptoms other than tiredness from lack of sleep due to chills and pain during the night.
Itching and rash at vacinnation site.  Itching began immediately and rash appeared later and hasgotten worse each day.
blood clot; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A male patient received bnt162b2 (COVID-19 VACCINE NOS MANUFACTURER UNKNOWN), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: THROMBOSIS (disability, medically significant), outcome "unknown", described as "blood clot". Patient had the covid vaccine and all boosters... until now. He got a blood clot.   No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300366229 Same reporter/ drug/ patient, different AE;
Bad blotchy rash over entire torso and upper inner arms, up the back of neck and into hair. Went to Urgent Care and ER. They had no idea what the rash was and suggested taking Benadryl which I have been doing. 9 days later rash is the same. Nausea and pressure in chest like indigestion. Nausea lasted a day. Chest pressure lasted 11 days. EKG, bloodwork and chest x ray were all ok. Not given anything for symptoms.
Mother noticed red tender swelling of left upper arm of child 5/17/06 4:30PM. On Exam 5/18/06 child had 8 x 12cm, red, tender, warm, swelling of left upper arm and mild non tender swelling of part of left fore arm.
Information has been received from a 73 year old male with an allergry to dust with no pertinent medical history who on 06-APR-2007 was vaccinated with Zostavax (Merck). Concomitant therapy included LANOXIN, PRILOSEC and "Rithinol". On approximately 08-APR-2007, the patient developed shingles on his scalp and neck. The patient presented to the emergency room where he was diagnosed with shingles. No lab testing was performed. The patient's shingles on his scalp and neck persisted. He was scheduled to see his primary physician in 2 weeks time. In follow-up the physician reported that the patient had developed herpes simplex type rash on the neck and secondary impetigo. The patient was treated with Bactrim. No lab testing was performed. Patient outcome was unknown. In follow-up the physician reported that the patient had shingles onset on 10-Apr-2007 and post herpetic neuralgia scalp. The patient's outcome was unknown. The patient was a dermatologist and the doctor diagnosed condition on "Pamvir".  Additional information has been requested.